2021-01-10,"Lifshitz Law Firm, P.C. Announces Investigation of CIT, CPAH, INFO, MTSC, NAV, STND, UROV, and WTRE"
2021-01-08,"MERGER INVESTIGATION: Halper Sadeh LLP Investigates CBMG, ALSK, UROV, NAV; Shareholders Are Encouraged to Contact the Firm"
2021-01-07,STOCKHOLDER ALERT: Monteverde & Associates Continues to Investigate the Following Merger
2021-01-05,"ALERT: Halper Sadeh LLP Investigates WTRE, CIT, ALSK, NAV, UROV; Shareholders Are Encouraged to Contact the Firm"
2021-01-03,"Lifshitz Law Firm, P.C. Announces Investigation of CBMG, CBLI, WORK, and UROV"
2020-12-30,"SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Mergers  UROV, EIGI, SNCA, CLCT"
2020-12-29,"SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of UROV, SNSS, TCF, and PS Mergers"
2020-12-28,"SHAREHOLDER ALERT: WeissLaw LLP Reminds UROV, WTRE, EIGI, and TNAV Shareholders About Its Ongoing Investigations"
2020-12-28,"SHAREHOLDER ALERT: Halper Sadeh LLP Investigates the Following Companies -UROV, INFO, WDR, CKH, EIGI"
2020-12-28,"Lifshitz Law Firm, P.C. Announces Investigation of WORK, TGC, UROV, and WDR"
2020-12-23,Urovant Sciences Announces U.S. FDA Approval of GEMTESAÂ® (vibegron) 75 mg Tablets for the Treatment of Patients with Overactive Bladder (OAB)
2020-12-22,"SHAREHOLDER ALERT: Halper Sadeh LLP Investigates the Following Companies  WDR, WORK, INFO, UROV"
2020-12-19,"Lifshitz Law Firm, P.C. Announces Investigation of ANH, RC, CPAH, GIK, MTSC, WORK, CRM, TGC, UROV, and WDR"
2020-12-19,"SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Companies - CKH, HBAN, PS, UROV, XLNX"
2020-12-17,"SHAREHOLDER ALERT: WeissLaw LLP Reminds SFBK, ACAM, CBLI, and UROV Shareholders About Its Ongoing Investigations"
2020-12-17,"SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of WDR, CLCT, NAV, and UROV Buyouts"
2020-12-16,"SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Companies  EIGI, XLNX, UROV, HDS"
2020-12-15,"MERGER ALERT - UROV, CGRO, and CKH: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Mergers of These Companies"
2020-12-12,"INVESTIGATION ALERT: Halper Sadeh LLP Continues to Investigate the Following Companies; Shareholders are Encouraged to Contact the Firm - EIGI, CKH, UROV, PNM, INFO"
2020-12-09,"WeissLaw LLP Reminds UROV, NAV, PNM, and MVC Shareholders About Its Ongoing Investigations"
2020-12-08,"INVESTIGATION ALERT: Halper Sadeh LLP Reminds Shareholders About Its Ongoing Merger Investigations; Investors are Encouraged to Contact the Firm  CKH, EIGI, HDS, UROV"
2020-12-07,"MERGER ALERT - UROV and GV: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Mergers of these Companies"
2020-12-04,"INVESTIGATION ALERT: Halper Sadeh LLP Reminds Shareholders About Its Ongoing Merger Investigations; Investors are Encouraged to Contact the Firm - WORK, WDR, BBIO, UROV, HDS"
2020-12-03,"UROVANT SCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Urovant Sciences - UROV"
2020-12-02,Is Urovant Sciences Ltd. (UROV) A Good Stock To Buy?
2020-12-01,"NOTICE - IMPORTANT SHAREHOLDER INVESTIGATION UPDATE: Brodsky & Smith, LLC Reminds Investors of Investigations Related to the Following Companies: Collectors Universe, Inc. (NASDAQ:CLCT), Urovant Sciences Ltd. (NASDAQ:UROV), HD Supply Holdings, Inc. (NASDAQ:HDS)"
2020-12-01,"Halper Sadeh LLP Reminds Shareholders About Its Ongoing Merger Investigations; Investors are Encouraged to Contact the Firm  NAV, UROV, HDS, AKER"
2020-12-01,SHAREHOLDER ALERT: Monteverde & Associates Continues to Investigate the Following Merger
2020-12-01,"SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of NAV, UROV, AKER, and EMIS Mergers"
2020-11-30,"WeissLaw LLP Reminds CCR, TCO, UROV, and PTI Shareholders About Its Ongoing Investigations"
2020-11-30,"SHAREHOLDER ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Investors are Encouraged to Contact the Firm - GV, HDS, UROV, TNAV"
2020-11-30,"MERGER ALERT  HDS, and UROV: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Mergers of these Companies"
2020-11-25,"Halper Sadeh LLP Continues to Investigate the Following Mergers; Investors are Encouraged to Contact the Firm  UROV, HDS, AKER, GV"
2020-11-25,"Lifshitz Law Firm, P.C. Announces Investigation of AKER, EMIS, HDS, IPHI, PNM, TGC, GV and UROV"
2020-11-24,"NOTICE - IMPORTANT SHAREHOLDER INVESTIGATION UPDATE: Brodsky & Smith, LLC Reminds Investors of Investigations Related to the Following Companies: Foundation Building Materials, Inc. (NYSE: FBM), Urovant Sciences Ltd. (Nasdaq - UROV), HD Supply Holdings, Inc. (Nasdaq - HDS)"
2020-11-24,Urovant Sciences Announces Topline Data from Phase 2a Study of Vibegron for the Treatment of Irritable Bowel Syndrome (IBS) Pain Did Not Meet Primary Endpoint
2020-11-24,STOCKHOLDER ALERT: Monteverde & Associates Continues to Investigate the Following Merger
2020-11-23,"SHAREHOLDER ALERT: WeissLaw LLP Reminds UROV, CIT, HLIX, and CBLI Shareholders About Its Ongoing Investigations"
2020-11-20,"ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Investors are Encouraged to Contact the Firm  HDS, AKER, UROV"
2020-11-20,"Moore Kuehn Encourages DNKN, HDS, CEIX and UROV Investors to Contact Law Firm"
2020-11-19,"SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of HDS, UROV, AKER, and TGC Mergers"
2020-11-19,Urovant Sciences Announces Positive Clinical Efficacy and Safety Data from Vibegron EMPOWUR Long Term Extension Study
2020-11-18,"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into the Fairness of the Sale of Urovant Sciences Ltd. to Sumitovant Biopharma"
2020-11-18,RM LAW Announces Investigation of Urovant Sciences Ltd.
2020-11-18,"SHAREHOLDER ALERT: Halper Sadeh LLP Reminds Investors of Its Ongoing Merger Investigations; Shareholders are Encouraged to Contact the Firm  BSTC, UROV, CXO"
2020-11-18,STOCKHOLDER ALERT: Monteverde & Associates Continues to Investigate the Following Merger
2020-11-18,"Halper Sadeh LLP Investigates the Following Mergers; Shareholders are Encouraged to Contact the Firm  HDS, UROV, AKER, NAV"
2020-11-17,"UROVANT SCIENCES INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Urovant Sciences - UROV"
2020-11-14,Top 5 Stock Gainers on Friday: Urovant Sciences Rises
2020-11-13,"SHAREHOLDER ALERT: Halper Sadeh LLP Investigates the Following Mergers; Investors are Encouraged to Contact the Firm  TNAV, ALSK, NAV, UROV"
2020-11-13,SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Urovant Sciences Ltd. - UROV
2020-11-13,"SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Urovant Sciences Ltd. (Nasdaq - UROV)"
2020-11-13,"SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Urovant Sciences Ltd. Buyout"
2020-11-13,"UROVANT ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of UROV and Encourages Investors to Contact the Firm"
2020-11-13,SHAREHOLDER ALERT: WeissLaw LLP Investigates Urovant Sciences Ltd.
2020-11-13,Why Urovant Sciences Stock Is Skyrocketing Today
2020-11-13,Urovant Sciences Skyrockets After Sale to Largest Shareholder
2020-11-13,Urovant Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Urovant Sciences Ltd. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm  UROV
2020-11-13,"The Daily Biotech Pulse: Urovant In M&A Deal, Sanofi's Binary Event, Conference Presentations"
2020-11-12,Urovant Sciences Enters Into Definitive Agreement for Sumitovant Biopharma to Acquire All Outstanding Shares
2020-11-12,Sumitovant Biopharma and Urovant Sciences Announce Sumitovant's Acquisition of Remaining Stake in Urovant
2020-11-10,Urovant Sciences to Present at the Jefferies Virtual London Healthcare Conference
2020-11-02,UROVANT SCIENCES LTD (UROV) Q2 2020 Earnings Call Transcript
2020-11-02,Urovant Sciences Reports Second Quarter Fiscal Year 2020 Results
2020-11-02,Urovant Sciences Ltd. to Host Earnings Call
2020-10-27,Urovant Sciences to Report Second Fiscal Quarter 2020 Financial Results
2020-10-07,Urovant Sciences Announces Co-Promotion Agreement for Vibegron with Sunovion Pharmaceuticals
2020-09-28,Tiny Axonics Modulation Rises To Stock Of The Day On Gains Vs. Giant Medtronic
2020-09-08,Urovant Sciences to Present at the H.C. Wainwright & Co. Annual Global Investment Conference
2020-08-13,UROVANT SCIENCES LTD (UROV) Q1 2020 Earnings Call Transcript
2020-08-13,Urovant Sciences Reports Fiscal First Quarter 2020 Results
2020-08-06,Urovant Sciences to Report First Fiscal Quarter 2020 Financial Results
2020-06-18,Urovant Sciences Reports Fiscal Year and Fourth Quarter 2019 Results
2020-06-18,Urovant Sciences Ltd. to Host Earnings Call
2020-06-18,Urovant Sciences Announces Collaboration with Sunovion Pharmaceuticals
2020-06-14,Hedge Funds Never Been Less Bullish On Urovant Sciences Ltd. (UROV)
2020-06-11,Urovant Sciences to Report Fiscal Year and Fourth Quarter 2019 Results
2020-06-02,"Urovant Sciences Appoints Walt Johnston as Senior Vice President of Commercial, Kenton Stewart as Senior Vice President of Market Access"
2020-05-27,Urovant Sciences Appoints James Hindman to Board of Directors
2020-05-26,Urovant Sciences to Present at the Jefferies Virtual Healthcare Conference
2020-05-14,Urovant Sciences Presents Positive Clinical Efficacy & Safety Data on Lead Drug Candidate Vibegron at Virtual American Urological Association Annual Meeting
2020-03-23,Urovant Sciences Appoints James Robinson as President and Chief Executive Officer
2020-03-05,Urovant Sciences Announces U.S. FDA Acceptance of New Drug Application for Vibegron for the Treatment of Overactive Bladder
2020-03-02,Urovant Sciences Announces Publication of Phase 3 EMPOWUR Trial Results in the Journal of Urology
2020-02-25,Urovant Sciences to Present at Cowen and Companys 40th Annual Health Care Conference
2020-02-13,Urovant Sciences Reports 2019 Third Fiscal Quarter Financial Results
2020-02-06,Urovant Sciences to Report 2019 Third Fiscal Quarter Financial Results
2020-02-04,Urovant Sciences Announces Publication of Results from Phase 1 Clinical Trials Evaluating URO-902 Gene Therapy in Patients with Overactive Bladder
2020-01-17,Urovant Sciences to Ring the Nasdaq Stock Market Opening Bell
2020-01-08,Urovant Sciences to Present at the 38th Annual J.P. Morgan Healthcare Conference
2020-01-02,"Company News For Jan 2, 2020"
2020-01-02,"The Daily Biotech Pulse: Canadian Approval For Amarin's Vascepa, Innate Pharma's Blood Cancer Drug Accepted For Review In Europe"
2019-12-31,Urovant Sciences Trades Higher After Submitting Application For Overactive Bladder Treatment
2019-12-30,Urovant Sciences Announces Submission of New Drug Application for Vibegron for the Treatment of Overactive Bladder
2019-12-30,Urovant Sciences Enters into $300 Million Term Loan Agreement with Sumitomo Dainippon Pharma
2019-12-30,"Urovant Sciences Majority Shareholder, Roivant Sciences, and Sumitomo Dainippon Pharma Complete Transaction for Strategic Alliance"
2019-12-23,Urovant Sciences Initiates Patient Enrollment in Phase 2a Study of URO-902
2019-12-16,Urovant Sciences Ltd. (UROV): Are Hedge Funds Right About This Stock?
2019-11-05,Urovant Sciences Reports 2019 Second Fiscal Quarter Financial Results
2019-10-31,"Urovant Sciences Secures Substantial Financial Commitment, Commercial Infrastructure Support and Minority Shareholder Protections from Sumitomo Dainippon Pharma Upon Close of Sumitomo Dainippon Pharmas Transaction with Roivant Sciences"
